Science

Scientists reveal how deadly Andes hantavirus attaches to human cells

Read full article at source ↗

Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 21/10/2026, 15:10:24 UTC.

Briefings

Scientists at Albert Einstein College of Medicine and Institut Pasteur revealed how Andes hantavirus attaches to human cells, a breakthrough that could lead to effective therapies. This study builds on a 2026 cruise ship outbreak where three passengers died and 13 were sickened, highlighting the urgent need for new treatments since no approved vaccines or cures exist for the virus.

Key points

• A study published in Nature details the molecular mechanism by which Andes hantavirus recognizes and binds to specific receptors on human cells.
• The research team includes researchers from Albert Einstein College of Medicine, Institut Pasteur, and LSU Health Shreveport.

Context

This research addresses a critical gap in medical science, as the 2026 cruise ship outbreak demonstrated the lethal nature of the virus and the immediate lack of approved vaccines or treatments for Andes virus and other hantaviruses.

Limitations

The evidence is limited to the findings of a single published study in Nature. The study does not provide data on the specific molecular receptors identified, nor does it offer clinical trial results or long-term efficacy data for potential therapies.

Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 21/10/2026, 15:14:54 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.

View archived briefing on IPFS
bafybeih6czhezbywaffpqanxgvamjzaf4x6ffd7a6rpxmerzslavxcfgbu